A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer

Published:2005 Issue:4 Volume:69 Page:333-341
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Kosmas Christos,Tsavaris Nicolas,Koutras Aggelos,Makatsoris Thomas,Mylonakis Nicolas,Tzelepis George,Dimitrakopoulos Antonis,Spyropoulos Konstantinos,Polyzos Aristidis,Karabelis Athanasios,Kalofonos Haralambos P.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference44 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

2. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

3. Ettinger DS: Ifosfamide in the treatment of non-small cell lung cancer. Semin Oncol 1989(suppl 3);16:31-38.

4. Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare

5. Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer;Lung Cancer;2010-05

2. A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens;Cancer Chemotherapy and Pharmacology;2006-04-19